Extracellular vesicles in heart failure - A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting

被引:7
作者
Matan, Dmitri [1 ,2 ]
Mobarrez, Fariborz [3 ]
Lofstrom, Ulrika [4 ,5 ]
Corbascio, Matthias [6 ]
Ekstrom, Mattias [1 ,7 ]
Hage, Camilla [2 ,3 ]
Lynga, Patrik [8 ]
Persson, Bengt [9 ]
Eriksson, Maria [6 ]
Linde, Cecilia [2 ,3 ]
Persson, Hans [1 ,7 ]
Wallen, Hakan [1 ,7 ]
机构
[1] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden
[2] Karolinska Univ Hosp, Heart & Vasc Theme, Stockholm, Sweden
[3] Uppsala Univ, Dept Med Sci, Div Clin Chem, Uppsala, Sweden
[4] Capio St Goran Hosp, Dept Med, Stockholm, Sweden
[5] Karolinska Inst, Dept Med, Stockholm, Sweden
[6] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[7] Danderyd Hosp, Dept Cardiol, Stockholm, Sweden
[8] Soder Sjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden
[9] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
关键词
extracellular vesicles; heart failure; Connexin-43; Caveolin-3; troponin-T; myeloperoxidase; Pentraxin-3; VE-cadherin; VASCULAR ENDOTHELIAL CADHERIN; DYSFUNCTION; MICROPARTICLES; ASSOCIATION; PENTRAXIN; DISEASE;
D O I
10.3389/fcvm.2022.952974
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsExtracellular vesicles (EVs) were investigated as potential biomarkers associated with heart failure (HF) pathophysiology in patients undergoing elective coronary artery bypass surgery characterized by HF phenotype. Materials and methodsPatients with preoperative proxy-diagnoses of HF types i.e., preserved (HFpEF; n = 19) or reduced ejection fraction (HFrEF; n = 20) were studied and compared to patients with normal left ventricular function (n = 42). EVs in plasma samples collected from the coronary sinus, an arterial line, and from the right atrium were analyzed by flow cytometry. We studied EVs of presumed cardiomyocyte origin [EVs exposing Connexin-43 + Caveolin-3 (Con43 + Cav3) and Connexin-43 + Troponin T (Con43 + TnT)], of endothelial origin [EVs exposing VE-Cadherin (VE-Cad)] and EVs exposing inflammatory markers [myeloperoxidase (MPO) or pentraxin3 (PTX3)]. ResultsMedian concentrations of EVs exposing Con43 + TnT and Con43 + Cav3 were approximately five to six times higher in coronary sinus compared to radial artery indicative of cardiac release. Patients with HFrEF had high trans-coronary gradients of both Con43 + TnT and Con43 + Cav3 EVs, whereas HFpEF had elevated gradients of Con43 + Cav3 EVs but lower gradients of Con43 + TnT. Coronary sinus concentrations of both Con43 + TnT and Con43 + Cav3 correlated significantly with echocardiographic and laboratory measures of HF. MPO-EV concentrations were around two times higher in the right atrium compared to the coronary sinus, and slightly higher in HFpEF than in HFrEF. EV concentrations of endothelial origin (VE-Cad) were similar in all three patient groups. ConclusionCon43 + TnT and Con43 + Cav3 EVs are released over the heart indicating cardiomyocyte origin. In HFrEF the EV release profile is indicative of myocardial injury and myocardial stress with elevated trans-coronary gradients of both Con43 + TnT and Con43 + Cav3 EVs, whereas in HFpEF the profile indicates myocardial stress with less myocardial injury.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Heart failure with preserved ejection fraction
    Harper, Andrew R.
    Patel, Hitesh C.
    Lyon, Alexander R.
    CLINICAL MEDICINE, 2018, 18 (02) : S24 - S29
  • [22] Heart failure with a preserved ejection fraction
    Warriner, D. R.
    Morris, P. D.
    Saraf, K.
    Al-Mohammad, A.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (02) : C26 - C30
  • [23] Heart failure with preserved ejection fraction
    James D. Gladden
    Wolfgang A. Linke
    Margaret M. Redfield
    Pflügers Archiv - European Journal of Physiology, 2014, 466 : 1037 - 1053
  • [24] Heart Failure with Preserved Ejection Fraction
    Michelle Mitchell
    Current Emergency and Hospital Medicine Reports, 2019, 7 : 184 - 188
  • [25] Heart Failure with Preserved Ejection Fraction
    Mitchell, Michelle
    CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS, 2019, 7 (04) : 184 - 188
  • [26] Heart failure with preserved ejection fraction
    Rigolli, Marzia
    Whalley, Gillian A.
    JOURNAL OF GERIATRIC CARDIOLOGY, 2013, 10 (04) : 369 - 376
  • [27] Heart Failure with Preserved Ejection Fraction
    Redfield, Margaret M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) : 1868 - 1877
  • [28] Heart Failure with Preserved Ejection Fraction
    Cannata, Antonio
    Mcdonagh, Theresa A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (02) : 173 - 184
  • [29] Heart failure with preserved ejection fraction
    Reda, S.
    Motloch, L. J.
    Hoppe, U. C.
    KARDIOLOGE, 2011, 5 (03): : 237 - 243
  • [30] Stroke in patients with heart failure and reduced or preserved ejection fraction
    Yang, Mingming
    Kondo, Toru
    Butt, Jawad H.
    Abraham, William T.
    Anand, Inder S.
    Desai, Akshay S.
    Kober, Lars
    Packer, Milton
    Pfeffer, Marc A.
    Rouleau, Jean L.
    Sabatine, Marc S.
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael R.
    Jhund, Pardeep S.
    McMurray, John J., V
    EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2998 - 3013